Chemkart India Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | July 7, 2025 to July 9, 2025 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Issue Price Band | ₹ 236 to ₹ 248 per share |
| Lot Size | 600 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 32,29,200 shares (aggregating up to ₹ 80.08 Cr) |
| Reserved for Market Maker | 1,66,200 shares (aggregating up to ₹ 4.12 Cr) |
| Fresh Issue (Ex Market Maker) | 24,33,800 shares (aggregating up to ₹ 60.36 Cr) |
| Offer for Sale | 6,29,200 shares of ₹10 (aggregating up to ₹ 15.60 Cr) |
| Net Offered to Public | 30,63,000 shares (aggregating up to ₹ 75.96 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 94,99,000 shares |
| Share Holding Post Issue | 1,20,99,000 shares |
About Chemkart India Limited IPO
Chemkart India Limited is launching its IPO under the SME category, aiming to raise ₹80.08 crore through a combination of a fresh issue (26,00,000 shares) and an offer for sale (OFS) of 6,29,200 shares by promoters Ankit Mehta and Parul Mehta. The IPO subscription window is open from July 7 to July 9, 2025. The price band, lot size, and further details are available on leading financial platforms.
Company Background
Chemkart India Private Limited is a company established in the year 2015 and is based in Mumbai, India. Chemkart India, a leading company known for its fascinating supplement products as well as components in nutrition, health, sports and wellness. The products of Chemkart are provided to companies for them to use in manufacturing supplements and products related to sports, nutrition and health. The B2B segment allows the company to offer its exceptional products with a customer-first priority to deliver the finest products.
Operations & Product Range
Facility & Production:
Chemkart operates a 28,259.16 sq. ft. processing and warehousing facility in Bhiwandi, Maharashtra, with blending (450 MT/year) and grinding (540 MT/year) capacities. The facility is equipped for blending, grinding, packaging, labelling and sealing nutraceutical ingredients, supporting both trading and limited value-added processing. Furthermore, the company’s warehouse processes, labels and finally seals the products in the best condition possible.
Brands & Market Presence:
The Chemkart India Limited IPO’s product range consists of 7 major categories of products and components that are Amino Acids, Health Supplements, Herbal Extract, Nucleotide, Protein, Sports Nutrition and Vitamin. With their vast market presence and a strong vendor base with a wide distribution network, they are known for their commitment to quality, customer relationships & efficient supply chain management. They do so by focusing on quality, reliability and timely delivery, aiming to be a one-stop solution for the food and health sectors.
Revenue Model
Chemkart India Limited generates its revenue by selling these ingredients to businesses across various sectors, including nutraceuticals, pharmaceuticals and food processing. As a distributor of food and health ingredients, Chemkart bridges the gap between global ingredient manufacturers and businesses, offering end-to-end solutions from sourcing to supply chain management. Their revenue streams are derived from the sale of these ingredients.
Management & Shareholding
Promoters
Chemkart India is managed by Mr. Ankit Shaileesh Mehta, Ms. Parul Shaileesh Mehta and Mr. Shaileesh Vinodrai Mehta, who are also promoters. The company has a 100% pre-issue promoter shareholding.
Board Members
The board is led by Ankit Shailesh Mehta, who is also the Managing Director and Owner of the company, bringing 11 years of experience in the industry.
IPO Objectives
- Capital Expenditure: ₹34.68 crore (53.78%) to fund facility upgrades and expansion.
- Debt Repayment: ₹20 crore (31.02%) to reduce outstanding borrowings.
- General Corporate Purposes: The remainder will be used for working capital and other business needs.
Conclusion
Chemkart India Limited’s IPO offers investors exposure to a high-growth B2B nutraceutical supplier with a robust trading model, strong revenue growth (54% YoY in FY25), and significant market presence in the health ingredients sector. However, risks include heavy dependence on imports, thin trading margins, and limited proprietary branding. The IPO proceeds are aimed at strengthening infrastructure and reducing debt, potentially supporting future margin expansion if the company pivots toward higher-value processing and formulation services.
Chemkart India Limited IPO Financial Information
Latest Revenue
205.46
₹ Crore
Profit After Tax
24.26
₹ Crore
Net Worth
53.29
₹ Crore
Total Borrowing
17.03
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 86.12 | 205.46 | 24.26 | 53.29 | 17.03 | ||||
| 31 Mar 2024 | 54 | 133 | 15 | 29.01 | 12.55 | ||||
| 31 Mar 2023 | 37.48 | 131.69 | 7.66 | 14.5 | 11.33 | ||||
| Amount in ₹ Crore | |||||||||
Chemkart India Limited Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 59% |
| ROCE | 49% |
| Debt/Equity | 0.32 |
| RoNW | 45.52% |
| EBITDA Margin | 16.12% |
| Price to Book Value | 8.12 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 25.54 | 20 |
| P/E (x) | 9.71 | 12 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Diversified Product Portfolio: Seven core categories cover a wide spectrum of nutraceutical ingredients.
In-house Facility: Enables hygienic and efficient processing, blending, and packaging.
Strong B2B Relationships: Repeat business from large buyers strengthens market position.
Certifications: FSSAI, ISO 9001:2015, Halal, and Kosher certifications ensure compliance and quality.
Scalable, Asset-light Model: Low capital intensity allows for rapid expansion and operational flexibility.
Strategic Location: Proximity to Mumbai port streamlines import logistics.
Download regulatory filings
Chemkart India Limited IPO Timeline
| IPO Open Date | Mon, Jul 7, 2025 |
| IPO Close Date | Wed, Jul 9, 2025 |
| Tentative Allotment | Thu, Jul 10, 2025 |
| Initiation of Refunds | Fri, Jul 11, 2025 |
| Credit of Shares to Demat | Fri, Jul 11, 2025 |
| Tentative Listing Date | Mon, Jul 14, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 9, 2025 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 1,200 | ₹2,97,600 |
| Individual investors (Retail) (Max) | 2 | 1,200 | ₹2,97,600 |
| HNI (Min) | 3 | 1,800 | ₹4,46,400 |